Daniele Bertoglio Selected Research

2- (6- chloro- 2- (4- (3- fluoropropoxy)phenyl)imidazo(1,2- a)pyridin- 3- yl)- N,N- diethylacetamide

1/2021	TSPO PET upregulation predicts epileptic phenotype at disease onset independently from chronic TSPO expression in a rat model of temporal lobe epilepsy.
3/2017	Non-invasive PET imaging of brain inflammation at disease onset predicts spontaneous recurrent seizures and reflects comorbidities.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniele Bertoglio Research Topics

Disease

7	Huntington Disease (Huntington's Disease) 01/2022 - 01/2018
5	Status Epilepticus (Complex Partial Status Epilepticus) 01/2021 - 10/2015
3	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2022 - 04/2020
3	Disease Progression 01/2022 - 01/2017
3	Nervous System Diseases (Neurological Disorders) 01/2021 - 01/2018
3	Epilepsy (Aura) 03/2017 - 10/2015
3	Temporal Lobe Epilepsy 01/2017 - 10/2015
1	Contusions 01/2022
1	Chronic Disease (Chronic Diseases) 01/2021
1	Neuroinflammatory Diseases 01/2021
1	Brain Diseases (Brain Disorder) 01/2020
1	Inflammation (Inflammations) 03/2017
1	Encephalitis (Encephalitis, Rasmussen) 10/2015
1	Substance-Related Disorders (Drug Abuse) 05/2013

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 11/2018 - 10/2015
4	Glycoproteins (Glycoprotein)IBA 10/2022 - 01/2020
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2015
4	Kainic Acid (Kainate)IBA 01/2021 - 10/2015
2	1- ((3- (methylpyridin- 4- yl)methyl)- 4- (3,4,5- trifluorophenyl)pyrrolidin- 2- oneIBA 01/2022 - 01/2022
2	2- (6- chloro- 2- (4- (3- fluoropropoxy)phenyl)imidazo(1,2- a)pyridin- 3- yl)- N,N- diethylacetamideIBA 01/2021 - 03/2017
2	Metabotropic Glutamate 5 ReceptorIBA 11/2018 - 01/2018
1	LigandsIBA 01/2022
1	polyglutamineIBA 01/2022
1	PK 11195 (PK11195)IBA 01/2021
1	Dopamine (Intropin)FDA LinkGeneric 01/2021
1	SCH 23390IBA 01/2021
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 04/2020
1	Glutamic Acid (Glutamate)FDA Link 04/2020
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2018
1	Staphylococcal Protein A (Protein A)IBA 03/2017
1	CytokinesIBA 01/2017
1	Interleukin-13IBA 01/2017
1	Ribosomal Protein S6IBA 05/2013
1	Ketamine FDA LinkGeneric 05/2013

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2017